+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Multiple Sclerosis Market and Competitive Landscape - 2020

  • ID: 5023471
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Multiple Sclerosis Market and Competitive Landscape - 2020, provides comprehensive insights into the Multiple Sclerosis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Multiple Sclerosis market size and drug sales. It also provides insights into Multiple Sclerosis epidemiology and late stage pipeline.

This research covers the following: Multiple Sclerosis treatment options, Multiple Sclerosis late stage clinical trials pipeline, Multiple Sclerosis prevalence by countries, Multiple Sclerosis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Multiple Sclerosis pipeline: Find out drugs in clinical trials for the treatment of Multiple Sclerosis by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Multiple Sclerosis epidemiology: Find out the number of patients diagnosed (prevalence) with Multiple Sclerosis by countries
  • Multiple Sclerosis drugs: Identify key drugs marketed and prescribed for Multiple Sclerosis in the US, including trade name, molecule name, and company
  • Multiple Sclerosis drugs sales: Find out the sales value for Multiple Sclerosis drugs by countries
  • Multiple Sclerosis market valuations: Find out the market size for Multiple Sclerosis drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Multiple Sclerosis drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Multiple Sclerosis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Multiple Sclerosis market
  • Develop in-depth knowledge of competition and markets
  • Analyze Multiple Sclerosis drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Multiple Sclerosis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Multiple Sclerosis Treatment Options

2. Multiple Sclerosis Pipeline Insights
2.1. Multiple Sclerosis Phase 3 Clinical Trials
2.2. Multiple Sclerosis Phase 2 Clinical Trials
2.3. Multiple Sclerosis Phase 1 Clinical Trials

3. Multiple Sclerosis Epidemiology Analysis by Countries

4. Germany Multiple Sclerosis Market Insights
4.1. Marketed Drugs for Multiple Sclerosis in Germany
4.2. Germany Multiple Sclerosis Market Size & Forecast
4.3. Germany Multiple Sclerosis Drugs Sales Forecast
4.4. Germany Multiple Sclerosis Market Share Analysis

5. France Multiple Sclerosis Market Insights
5.1. Marketed Drugs for Multiple Sclerosis in France
5.2. France Multiple Sclerosis Market Size & Forecast
5.3. France Multiple Sclerosis Product Sales Forecast
5.4. France Multiple Sclerosis Market Share Analysis

6. Italy Multiple Sclerosis Market Insights
6.1. Marketed Drugs for Multiple Sclerosis in Italy
6.2. Italy Multiple Sclerosis Market Size & Forecast
6.3. Italy Multiple Sclerosis Product Sales Forecast
6.4. Italy Multiple Sclerosis Market Share Analysis

7. Spain Multiple Sclerosis Market Insights
7.1. Marketed Drugs for Multiple Sclerosis in Spain
7.2. Spain Multiple Sclerosis Market Size & Forecast
7.3. Spain Multiple Sclerosis Product Sales Forecast
7.4. Spain Multiple Sclerosis Market Share Analysis

8. UK Multiple Sclerosis Market Insights
8.1. Marketed Drugs for Multiple Sclerosis in UK
8.2. UK Multiple Sclerosis Market Size & Forecast
8.3. UK Multiple Sclerosis Product Sales Forecast
8.4. UK Multiple Sclerosis Market Share Analysis

9. Europe Multiple Sclerosis Market Insights
9.1. Europe Multiple Sclerosis Market Size & Forecast
9.2. Europe Multiple Sclerosis Product Sales Forecast
9.3. Europe Multiple Sclerosis Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Multiple Sclerosis Phase 3 Clinical Trials, Global, 2020
Table 2: Multiple Sclerosis Phase 2 Clinical Trials, Global, 2020
Table 3: Multiple Sclerosis Phase 1 Clinical Trials, Global, 2020
Table 4: Multiple Sclerosis Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Multiple Sclerosis in Germany, 2019
Table 6: Germany Multiple Sclerosis Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Multiple Sclerosis Product Sales ($mn), 2016 - 2024
Table 8: Germany Multiple Sclerosis Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Multiple Sclerosis in France, 2019
Table 10: France Multiple Sclerosis Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Multiple Sclerosis Product Sales ($mn), 2016 - 2024
Table 12: France Multiple Sclerosis Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Multiple Sclerosis in Italy, 2019
Table 14: Italy Multiple Sclerosis Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Multiple Sclerosis Product Sales ($mn), 2016 - 2024
Table 16: Italy Multiple Sclerosis Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Multiple Sclerosis in Spain, 2019
Table 18: Spain Multiple Sclerosis Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Multiple Sclerosis Product Sales ($mn), 2016 - 2024
Table 20: Spain Multiple Sclerosis Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Multiple Sclerosis in UK, 2019
Table 22: UK Multiple Sclerosis Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Multiple Sclerosis Product Sales ($mn), 2016 - 2024
Table 24: UK Multiple Sclerosis Market Events and Trends, 2016 - 2024
Table 25: Europe Multiple Sclerosis Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Multiple Sclerosis Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Multiple Sclerosis Pipeline by Phase (%), Global, 2020
Figure 2: Multiple Sclerosis Prevalence by Countries, 2016 - 2024
Figure 3: Germany Multiple Sclerosis Market Size ($mn), 2016 - 2024
Figure 4: Germany Multiple Sclerosis Product Sales ($mn), 2016 - 2024
Figure 5: Germany Multiple Sclerosis Market Share by Drugs (%), 2019
Figure 6: Germany Multiple Sclerosis Market - Future Market Share (%), 2024
Figure 7: France Multiple Sclerosis Market Size ($mn), 2016 - 2024
Figure 8: France Multiple Sclerosis Product Sales ($mn), 2016 - 2024
Figure 9: France Multiple Sclerosis Market Share by Drugs (%), 2019
Figure 10: France Multiple Sclerosis Market - Future Market Share (%), 2024
Figure 11: Italy Multiple Sclerosis Market Size ($mn), 2016 - 2024
Figure 12: Italy Multiple Sclerosis Product Sales ($mn), 2016 - 2024
Figure 13: Italy Multiple Sclerosis Market Share by Drugs (%), 2019
Figure 14: Italy Multiple Sclerosis Market - Future Market Share (%), 2024
Figure 15: Spain Multiple Sclerosis Market Size ($mn), 2016 - 2024
Figure 16: Spain Multiple Sclerosis Product Sales ($mn), 2016 - 2024
Figure 17: Spain Multiple Sclerosis Market Share by Drugs (%), 2019
Figure 18: Spain Multiple Sclerosis Market - Future Market Share (%), 2024
Figure 19: UK Multiple Sclerosis Market Size ($mn), 2016 - 2024
Figure 20: UK Multiple Sclerosis Product Sales ($mn), 2016 - 2024
Figure 21: UK Multiple Sclerosis Market Share by Drugs (%), 2019
Figure 22: UK Multiple Sclerosis Market - Future Market Share (%), 2024
Figure 23: Europe Multiple Sclerosis Market Size ($mn), 2016 - 2024
Figure 24: Europe Multiple Sclerosis Product Sales ($mn), 2016 - 2024
Figure 25: Europe Multiple Sclerosis Market Share by Drugs (%), 2019
Figure 26: Europe Multiple Sclerosis Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll